Possible clinical applications of serenics and some implications of their preclinical profile for their clinical use in psychiatric disorders.
Rasmussen
D L
DL
Department of Pharmacology, Duphar B.V., Weesp, The Netherlands.
Olivier
B
B
Raghoebar
M
M
Mos
J
J
D000374:Aggression / Q000187:drug effects; D000378:Agonistic Behavior / Q000187:drug effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011083:Polycyclic Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000494:pharmacology / Q000627:therapeutic use*; D011985:Receptors, Serotonin / Q000502:physiology; D012701:Serotonin / Q000502:physiology
D011083:Polycyclic Compounds; D011619:Psychotropic Drugs; D011985:Receptors, Serotonin; D012701:Serotonin